Completed NA INTERVENTIONAL 2-arm NCT03378674

Remifentanil and Stress Hormones Response

Effect of Different Doses of Remifentanil on Stress Response During Laparoscopic Cholecystectomy

Sponsor: Catholic University of the Sacred Heart

Interventions Remifentanil Injectable Product

Updated 5 times since 2018 Last updated: Jan 5, 2018 Started: Jan 31, 2008 Primary completion: Jul 31, 2012 Completion: Jul 31, 2012

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

Listed as NCT03378674, this NA trial focuses on Stress Response and remains completed. Sponsored by Catholic University of the Sacred Heart, it has been updated 5 times since 2008, reflecting limited change activity. This study adds to the evidence base for this therapeutic area through structured, versioned documentation.

Status Flow

Change History

5 versions recorded

Sep 2024 — Present [monthly]

Completed NA
Jul 2024 — Sep 2024 [monthly]

Completed NA
Jan 2021 — Jul 2024 [monthly]

Completed NA
Jun 2018 — Jan 2021 [monthly]

Completed NA
Jan 2018 — Jun 2018 [monthly]

Completed NA

First recorded

Jan 2008

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Catholic University of the Sacred Heart

Data source: Catholic University of the Sacred Heart

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Rome, Italy